| Literature DB >> 32272754 |
Ylva Hedberg-Alm1, Johanna Penell2, Miia Riihimäki3, Eva Osterman-Lind4, Martin K Nielsen5, Eva Tydén6.
Abstract
All grazing horses are exposed to intestinal parasites, which have the potential to cause gastrointestinal disease. In Sweden, there is a concern about an increase in parasite-related equine gastrointestinal disease, in particular Strongylus vulgaris, since the implementation of prescription-only anthelmintics approximately 10 years ago. In a prospective case-control study, parasitological status, using fecal analyses for strongyle egg counts, the presence of Anoplocephala perfoliata eggs and S. vulgaris Polymerase chain reaction (PCR) as well as serology for S. vulgaris, were compared between horses presenting with or without gastrointestinal disease at a University hospital during a one-year period. Information regarding anthelmintic routines and pasture management was gathered with an owner-filled questionnaire. Although the prevalence of S. vulgaris PCR was 5.5%, 62% of horses were positive in the enzyme-linked immunosorbent assay (ELISA) test and horses with peritonitis showed higher antibody levels for S. vulgaris, as compared to other diagnoses or controls. Overall, 36% of the horse owners used only fecal egg counts (FEC), 32% used FEC combined with specific diagnostics for S. vulgaris or A. perfoliata, and 29% dewormed routinely without prior parasite diagnostics. Effective management methods to reduce the parasitic burden on pastures were rare and considering exposure to S. vulgaris appears high; the study indicates a need for education in specific fecal diagnostics and pasture management.Entities:
Keywords: Anoplocephala perfoliata; Strongylus vulgaris; colic; cyathostominae; gastrointestinal disease; horse
Year: 2020 PMID: 32272754 PMCID: PMC7222828 DOI: 10.3390/ani10040638
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Questionnaire data collected from participating cases and controls.
| Information | Descriptor |
|---|---|
| Age of horse | Years |
| Time in ownership | Years |
| Any previous history of colic a | Yes/No |
| If yes, specify number of colic episodes | Number |
| Treated for colic by a veterinarian during last 24 months | Yes/No |
| Signs of diarrhea b during last 2 months | Yes/No |
| Lost weight c during last 2 months | Yes/No |
| Last anthelmintic treatment (months) | 0–3; 3–6; 6–12; >12 |
| Drug used during last treatment | FBZ d; PYR e; IVM f; MOX g; COMB h |
| Deworming routines applied on the farm | (i) only after FEC i |
| Presence of parasites in fecal sample during last 24 months | Small strongyles; |
| Access to separate winter and summer pasture | Yes/No |
| Grazing with other animals species | Yes/No |
| Size of pasture or paddock, winter | Hectare |
| Size of pasture or paddock, summer | Hectare |
| Number of horses in pasture/paddock, winter | Number |
| Number of horses in pasture/paddock, summer | Number |
| Use of fecal removal | Yes/No |
| If yes, how often are feces removed | Number/week |
| Hours spent outdoors (paddock), winter | 1–24 |
| Hours spent outdoors (pasture), summer | 1–24 |
a restlessness and pawing at the ground, irritated kicking to the stomach, rolling or attempting to roll; b loose consistency of feces; c as subjectively appreciated by owner; d fenbendazole; e pyrantel; f ivermectin; g moxidectin; h ivermectin/moxidectin and praziquantel; i fecal egg count.
Distribution of gastrointestinal diagnoses in cases.
| Diagnosis | Number of Cases (% of Total Case Load) |
|---|---|
| Impaction (small colon, large colon, cecal) | 52 (38.0%) |
| Acute colitis | 14 (10.2%) |
| Large colon displacement | 13 (9.5%) |
| Peritonitis | 11 (8.0%) |
| Gas distention colic | 8 (5.8%) |
| Equine eosinophilic gastroenteritis/enterocolitis (EEG) | 5 (3.6%) |
| Chronic colitis | 3 (2.2%) |
| Undiagnosed | 21 (15.3%) |
| Other | 10 (7.3%) |
Results of questionnaire data: owner-reported previous medical history of cases and controls as outlined in a questionnaire presented after agreement of study participation. The p-value for statistical significance was corrected for the number of analyses (n = 5) according to Bonferroni, i.e., p < 0.01 (0.05/5).
| Information | Cases | Controls | OR (95% C.I.) | |
|---|---|---|---|---|
| Prevalence with previous history of colic a (%) | 50.4% | 23.9% | 3.13 (1.83–5.35) | <0.01 |
| Number of previous colic episodes (mean ± SD) | 2.2 (± 2.3) | 1.8 (± 1.9) | 1.09 (0.86–1.39) | 0.47 |
| Prevalence treated for colic during last 24 months (%) | 33.3% | 8% | 5.73 (2.78–11.84) | <0.01 |
| Prevalence with diarrhea b during last 2 months | 15.8% | 7.5% | 0.42 (0.18–0.94) | 0.03 |
| Prevalence with weight loss c during last 2 months | 9.2% | 6.0% | 0.45 (0.18–1.10) | 0.08 |
a restlessness and pawing at the ground, irritated kicking to the stomach, rolling or attempting to roll; b loose consistency of feces; c as subjectively appreciated by owner.
Result of questionnaire data: anthelmintic routines. The p-value for statistical significance was corrected for the number of analyses (n = 4) according to Bonferroni, i.e., p < 0.01 (0.05/4).
| Information | Cases | Controls | |
|---|---|---|---|
|
| |||
| 0–3 | 17.9% | 19.7% | 0.38 |
| 3–6 | 28.6% | 22.7% | 0.40 |
| 6–12 | 26.8% | 34.8% | 0.66 |
| >12 | 26.8% | 22.7% | 0.51 |
| For the variable (all time groups) cases/controls: | 0.46 | ||
|
| |||
| FBZ a | 4.5% | 2.3% | 0.48 |
| PYR b | 3.6% | 6.9% | 0.16 |
| MOX c | 3.6% | 3.1% | 0.62 |
| IVM d | 35.5% | 46.9% | 0.21 |
| COMB e | 10% | 17.7% | 0.13 |
| Unknown | 42.7% | 23.1% | 0.94 |
| For the variable (all drug groups) cases/controls: | 0.02 | ||
|
| |||
| (i) after FEC f | 35.7% | 35.8% | 0.99 |
| (ii) after FEC and | 30.2% | 33.6% | 0.55 |
| (iii) diagnostics for | 13.5% | 18.7% | 0.26 |
| (iv) routine deworming once/year | 13.5% | 11.1% | 0.57 |
| (v) routine deworming 2–4 times/year | 12.7% | 20.1% | 0.11 |
|
| |||
| Cyathostomins | 29.4% | 36.8% | 0.13 |
|
| 6.9% | 2.6% | 0.10 |
|
| 1.0% | 1.7% | 0.79 |
| 1.0% | 1.7% | 0.79 | |
| Do not know | 61.8% | 57.3% | 0.31 |
a fenbendazole; b pyrantel; c ivermectin; d moxidectin; e ivermectin/moxidectin and praziquantel; f fecal egg count.
Results of questionnaire data: pasture management. The p-value for statistical significance was corrected for the number of analyses (n = 10) according to Bonferroni, i.e., p < 0.005 (0.05/10).
| Information> | Cases | Controls | |
|---|---|---|---|
| Access to separate summer/winter paddocks | 67.5% | 60.9% | 0.27 |
| Grazing with other animal species | 10.6% | 9.0% | 0.67 |
| Fecal removal | | | |
| Fecal removal from pasture, ≥2x/week | 5.9% | 8.1% | 0.33 |
| Time stabled/outdoors | | | |
| Stabled > 12 h/d, winter | 65% | 55.6% | 0.13 |
| Outdoors 24h/d, summer | 54.2 | 54.8% | 0.96 |
| Stabled > 12 h/d, summer | 26.7% | 26.7% | 0.93 |
| Stocking density | | | |
| Stocking density, winter (hectare/horse) | 0.4 | 0.4 | 0.22 |
Fecal and serology results in cases and controls. The p-value for statistical significance was corrected for the number of analyses (n = 4) according to Bonferroni, i.e., p < 0.01 (0.05/4).
| Investigated Parameter | Cases n (%) | Controls n (%) | |
|---|---|---|---|
| EPG a level LOW | 93 (67.9%) | 92 (67.1%) | 0.92 |
| EPG a level MEDIUM | 19 (13.9%) | 25 (18.2%) | |
| EPG a level HIGH | 25 (18.3%) | 20 (14.6%) | |
| 7 (5.2%) | 8 (5.8%) | 0.80 | |
| 75 (61.5%) | 86 (62.8%) | 0.83 | |
|
| 17 (12.4%) | 26 (19.0%) | 0.14 |
a EPG, eggs per gram of feces.
Figure 1A boxplot illustrating the quantitative enzyme-linked immunosorbent assay (ELISA) values for each colic diagnosis compared with their matched controls. The bold line indicates median, the dotted line indicates the cut-off (13.47) value for positive ELISA.